ICAM1 and cancer: In addition, to unlock the potential of ADC for cancer therapy, we also sought to develop a strategy to enhance the efficacy of ICAM1‐ADC through combination with DAC, although the efficacy of ICAM1‐ADC as a single agent was remarkable across the preclinical models.